Gainers
-
Vaxart, Inc. (NASDAQ: VXRT) shares
surged 42.11 percent to close at $2.34 on Tuesday after the company initiated a Phase 1b clinical trial for its bivalent
norovirus vaccine.
-
Sorrento Therapeutics, Inc. (NASDAQ: SRNE) shares gained 39.64 percent to close at $3.84.
-
IMAC Holdings, Inc. (NASDAQ: IMAC)
shares gained 34.54 percent to close at $4.09.
-
Chaparral Energy, Inc. (NYSE: CHAP) rose
26.01 percent to close at $5.62.
-
The9 Limited (NASDAQ: NCTY) surged
24.88 percent to close at $2.56.
-
Realm Therapeutics Plc (NASDAQ: RLM)
climbed 23.1 percent to close at $4.19.
-
Iterum Therapeutics plc (NASDAQ: ITRM)
rose 22.34 percent to close at $6.90. Iterum Therapeutics received QIDP for oral and intravenous formulations of sulopenem in
four additional indications as well as Fast Track designation.
-
Blucora Inc (NASDAQ: BCOR) gained
18.75 percent to close at $33.69 after the company reported a $100 million buyback, raised its FY19 EPS and sales guidance, and
announced it will acquire 1st Global for $180 million.
-
Aytu Bioscience Inc (NASDAQ: AYTU)
rose 18.6 percent to close at $2.04 after the company announced two recent publications highlighting summarized findings from
its MY-T study.
-
StoneCo Ltd. (NASDAQ: STNE) shares
surged 18.41 percent to close at $40.97 after the company reported higher-than-expected Q4 EPS and sales results.
-
Soliton, Inc. (NASDAQ: SOLY) gained
17.55 percent to close at $7.30. Soliton completed clinical trials for initial FDA filing for tattoo indication.
-
Aravive, Inc. (NASDAQ: ARAV) surged
16.52 percent to close at $7.69. Aravive announced retrospective analysis showing increased GAS6 levels associated with
chemoresistance and decreased progression free survival in ovarian cancer.
-
Miragen Therapeutics, Inc. (NASDAQ: MGEN) rose 16.49 percent to close at $3.32.
-
ENDRA Life Sciences Inc. (NASDAQ: NDRA) shares gained 16.18 percent to close at $2.80.
-
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) surged 14.67 percent to close at $5.57.
-
Altimmune, Inc. (NASDAQ: ALT) climbed
14.64 percent to close at $3.32 after reporting 'positive' results from NasoVAX extension study'.
-
Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) gained 14 percent to close at $11.40.
-
Forterra, Inc. (NASDAQ: FRTA) rose
13.27 percent to close at $4.58.
-
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) rose 12.99 percent to close at $3.48. Catalyst Pharmaceuticals reported
a loss of 14 cents per share compared to the loss of 6 cents per share a year ago and the 12 cents per share consensus
estimate. The company reported revenues of $500,000 for the recent fourth quarter.
-
Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares rose 12.9 percent to close at $12.95.
-
Blink Charging Co. (NASDAQ: BLNK)
shares gained 12.64 percent to close at $3.06 after the company announced a joint venture with Eunice Energy Group. The joint
venture will target European markets, starting with Greece.
-
Corindus Vascular Robotics, Inc. (NYSE: CVRS) shares rose 12.44 percent to close at $2.26.
-
Wrap Technologies, Inc. (NASDAQ: WRTC)
climbed 12.36 percent to close at $6.00.
-
Tredegar Corporation (NYSE: TG) rose 12.14
percent to close at $19.03 following Q4 earnings.
-
Dermira, Inc. (NASDAQ: DERM) gained
12.05 percent to close at $14.13. Dermira reported a $110 million common stock offering.
-
Advanced Micro Devices, Inc. (NASDAQ: AMD) gained 12.04 percent to close at $26.00. Shares of several semiconductor
companies are trading higher after NVIDIA teamed up with Amazon Web Services IoT to bring AI to millions of connected devices.
-
Evolus, Inc. (NASDAQ: EOLS) rose 11.74
percent to close at $26.57, despite reporting mixed Q4 EPS, after the company secured a $100 million debt facility with Oxford
Finance LLC.
-
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) climbed 11.04 percent to close at $18.50.
-
Arco Platform Limited (NASDAQ: ARCE)
gained 10.95 percent to close at $29.24.
-
Assertio Therapeutics, Inc. (NASDAQ: ASRT) rose 10.8 percent to close at $4.72.
-
Sibanye Gold Limited (NYSE: SBGL) rose
9.51 percent to close at $4.49.
-
Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) gained 8.88 percent to close at $7.47 after Oppenheimer initiated an
Outperform rating on the stock and announced a $28 price target.
-
Ferro Corporation (NYSE: FOE) gained 8.47
percent to close at $20.49 after S&P Dow Jones Indices announced that Ferro will replace First Financial Bankshares in the
S&P SmallCap 600 on Friday, March 22.
-
Michaels Companies Inc (NASDAQ: MIK)
rose 8.31 percent to close at $12.79 after reporting better-than-expected results for its fourth quarter.
-
Syneos Health, Inc. (NASDAQ: SYNH)
rose 8.25 percent to close at $51.40 after the company reported higher-than-expected Q4 EPS results. The company also issued
FY19 EPS guidance on the high-end of analyst estimates.
-
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) shares rose 7.18 percent to close at $28.22.
-
Professional Diversity Network, Inc. (NASDAQ: IPDN) gained 7.14 percent to close at $3.00.
-
SemiLEDs Corporation (NASDAQ: LEDS)
gained 6.74 percent to close at $3.80.
-
Tronox Ltd (NYSE: TROX) gained 5.22
percent to close at $12.70 following a media report the company will be selling its North American titanium dioxide business
for $700 million.
-
X Financial (NYSE: XYF) shares rose 4.7
percent to close at $6.47 following Q4 results.
-
Fiat Chrysler Automobiles N.V. (NYSE: FCAU) shares rose 4 percent to close at $15.11 after the Peugeot family hinted
it could be interested in acquiring Fiat as a part of PSA Group.
-
NVIDIA Corporation (NASDAQ: NVDA) rose
3.9 percent to close at $175.71 after the company teamed up with Amazon Web Services IoT to bring AI to millions of connected
devices.
Losers
-
resTORbio, Inc. (NASDAQ: TORC) tumbled
22.87 percent to close at $6.98 after the company reported Q4 results and announced a $50 million common stock offering.
-
Urovant Sciences Ltd (NASDAQ: UROV)
shares dropped 20.92 percent to close at $11.00 after the company announced its Vibegron met its primary endpoints in a phase 3
trial.
-
AquaBounty Technologies, Inc. (NASDAQ: AQB) dropped 20.36 percent to close at $2.2300. AquaBounty priced its 3.35
million share common stock offering at $2.25 per share.
-
Phunware Inc. (NASDAQ: PHUN) shares
dropped 18.63 percent to close at $41.50.
-
PHI, Inc. (NASDAQ: PHII) declined
18.47 percent to close at $2.02 following Q4 results.
-
Selecta Biosciences, Inc. (NASDAQ: SELB) shares declined 17.97 percent to close at $2.52.
-
Emerge Energy Services LP (NYSE: EMES)
fell 16.73 percent to close at $2.09.
-
Liquidia Technologies, Inc. (NASDAQ: LQDA) dipped 15.45 percent to close at $15.21 after reporting a proposed 3
million share common stock offering.
-
DSW Inc. (NYSE: DSW) shares dropped 12.89
percent to close at $22.09 after reporting downbeat quarterly earnings.
-
Daré Bioscience, Inc. (NASDAQ: DARE)
fell 12.45 percent to close at $1.80.
-
Orion Group Holdings, Inc. (NYSE: ORN)
shares dropped 12.26 percent to close at $3.72.
-
Cool Holdings, Inc. (NASDAQ: AWSM)
fell 12.1 percent to close at $3.10.
-
B Communications Ltd (NASDAQ: BCOM)
shares dropped 12.09 percent to close at $3.4800.
-
Globus Maritime Limited (NASDAQ: GLBS)
dipped 11.71 percent to close at $4.07.
-
Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares declined 11.63 percent to close at $2.28.
-
Pareteum Corporation (NASDAQ: TEUM)
dropped 11.4 percent to close at $5.05.
-
NanoString Technologies, Inc. (NASDAQ: NSTG) dipped 10.96 percent to close at $24.28 after reporting a 4.5 million
share common stock offering.
-
Titan Medical Inc. (NASDAQ: TMDI) fell
10.54 percent to close at $2.9950.
-
Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) fell 10.48 percent to close at $2.2200 after climbing 14.9439 percent on
Monday.
-
Gritstone Oncology, Inc. (NASDAQ: GRTS) dropped 9.97 percent to close at $11.92.
-
Bio-Path Holdings, Inc. (NASDAQ: BPTH)
dipped 9.68 percent to close at $25.20.
-
PFSweb, Inc. (NASDAQ: PFSW) fell 9.59
percent to close at $5.75 after reporting downbeat Q4 earnings.
-
Esperion Therapeutics, Inc. (NASDAQ: ESPR) dropped 9.48 percent to close at $43.95.
-
Covenant Transportation Group, Inc. (NASDAQ: CVTI) fell 8.36 percent to close at $19.61 on worse-than-expected Q1 guidance.
-
Revlon Inc (NYSE: REV) declined 6.87
percent to close at $18.02 after the company reported lower-than-expected Q4 EPS and sales results.
-
Del Taco Restaurants, Inc. (NASDAQ: TACO) fell 6.61 percent to close at $9.89 after the company reporter
lower-than-expected Q4 EPS results. The company also issued FY19 EPS guidance below analyst estimates and FY19 sales on the
low-end of analyst estimates.
-
Cactus Inc (NYSE: WHD) dropped 4.9
percent to close at $35.88 after a shareholder of the company priced an 8.5 million share offering at $36.25 per share.
-
Yext, Inc. (NYSE: YEXT) shares fell 4.2
percent to close at $22.04. Yext priced its 6.1 million share offering of common stock at $21.50 per share.
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.